Patents by Inventor Hyuk Kwon KWON

Hyuk Kwon KWON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide for toll-like receptor (TLR) inhibition and pharmaceutical composition comprising same
    Patent number: 11352399
    Abstract: The present invention relates to a fusion polypeptide that inhibits TLR1/2, TLR2/6, TLR7, TLR8 and TLR9 signaling pathways as well as Toll-like receptor 4 (TLR4) and TLR3, and a pharmaceutical composition for preventing or treating TLR pathway mediated diseases. The fusion peptide of the present invention has an excellent effect of inhibiting TLR4 and various TLR pathways and can be effectively used in preventing and treating various TLR pathway mediated diseases caused by the signaling pathways, such as autoimmune diseases, inflammatory diseases and degenerative neurological diseases, by inhibiting the TLR mediated immune responses.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: June 7, 2022
    Assignee: GENESEN CO., LTD.
    Inventors: Sang Dun Choi, Hyuk Kwon Kwon, Hyeon Jun Shin, Xiang Ai Gui
  • PEPTIDE FOR TOLL-LIKE RECEPTOR (TLR) INHIBITION AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
    Publication number: 20200140504
    Abstract: The present invention relates to a fusion polypeptide that inhibits TLR1/2, TLR2/6, TLR7, TLR8 and TLR9 signaling pathways as well as Toll-like receptor 4 (TLR4) and TLR3, and a pharmaceutical composition for preventing or treating TLR pathway mediated diseases. The fusion peptide of the present invention has an excellent effect of inhibiting TLR4 and various TLR pathways and can be effectively used in preventing and treating various TLR pathway mediated diseases caused by the signaling pathways, such as autoimmune diseases, inflammatory diseases and degenerative neurological diseases, by inhibiting the TLR mediated immune responses.
    Type: Application
    Filed: April 25, 2018
    Publication date: May 7, 2020
    Applicant: GENESEN CO., LTD.
    Inventors: Sang Dun CHOI, Hyuk Kwon KWON, Hyeon Jun SHIN, Xiang Ai GUI